feed info

9 articles from Yahoo!

Common cold antibodies hold clues to COVID-19 behavior; lung scans speed COVID-19 diagnosis in stroke patients

Among people who were never infected with the new coronavirus, a few adults - and many children - may have antibodies that can neutralize the virus, researchers reported on Friday in Science. Among 302 such adults, 16 (5.3%) had antibodies, likely generated during infections with "common cold" coronaviruses, that reacted to a specific region of the spike protein on the new virus called the S2...

Doctors debunk 15 flu myths

Two doctors debunk 15 of the most common myths about the flu, including how long the flu vaccine lasts, and why you have to get the flu shot...

Russian scientists discover huge walrus haulout in Artic circle

Scientists in northern Russia have discovered a huge walrus haulout on the shores of the Kara Sea where their habitat is under threat from shrinking ice and human activity. The haulout, a place of refuge where walruses congregate, reproduce, and socialise, is located in a remote corner of Russia's Yamal peninsula, and scientists say they counted over 3,000 animals there last month. Walrus...

Nasal Spray Prevents COVID Infection in Ferrets, Study Finds

A nasal spray that blocks the absorption of the SARS-CoV-2 virus has completely protected ferrets it was tested on, according to a small study released Thursday by an international team of scientists. The study, which was limited to animals and has not yet been peer-reviewed, was assessed by several health experts at the request of The New York Times.If the spray, which the scientists described as...

Aspirin to be tested as potential COVID-19 drug in UK study

The scientists behind the RECOVERY trial, which is looking into a range of potential treatments for COVID-19, said it would include the drug, which is commonly used as a blood thinner. "There is a clear rationale for believing that it (aspirin) might be beneficial, and it is safe, inexpensive and widely available," said Peter Horby, co-chief investigator of the trial. Patients infected with the...

Wealthy countries edge towards global climate finance goal

Wealthy countries have ramped up financing to help developing countries cut carbon emissions and cope with climate change impacts, although it is unclear if they will meet their goal of $100 billion this year. In its annual update on climate finance for developing countries, the Organisation for Economic Co-operation and Development (OECD) said donor governments contributed $78.9 billion in 2018,...

Celltrion's COVID-19 antibody drug cut recovery time-early study

The result bodes well for Celltrion, which plans to seek conditional approval for the monoclonal antibody treatment, CT-P59, for emergency use by the end of this year in South Korea. In its global Phase 1 trial that enrolled 18 patients with mild symptoms of COVID-19, 15 participants who received the treatment had a mean recovery time about 44% faster than three people in a placebo group....